First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti ‐proliferative drugs: Two‐year imaging results in humans
ConclusionAt 2 years, this novel PLLA‐based BRS induced expansive vascular remodeling from 6 to 24 months, a biological phenomenon that appears to be independent of the presence of anti‐proliferative drugs.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Miguel Moncada, Juan A. Delgado, Antonio Colombo, Pawel Gasior, Kamal Ramzipoor, Alex Estrada, Chang Lee, Danny Dokko, Juan F. Granada Tags: CORONARY ARTERY DISEASE Source Type: research
More News: Angiography | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Molecular Biology | Study | Ultrasound